Safety, efficacy and inhibitor risk of recombinant factor VIII (Recombinate) in a cohort of previously untreated patients (PUP’s) with severe hemophilia - Bray, G L; Courter, S G; Lynes, M; Lee, M; Gomperts, E (Thromb Haemost, 1993)
(Abstract)